APO RESEARCH · REPORT
Neuromodulation Devices and Implantable Infusion Pumps
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
Product & engineering
Understand the product.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
Selected research
Industry Research
Neuromodulation Devices and Implantable Infusion Pumps Industry Research Report 2026
Market perspective
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
Read the full market overview
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
Report Scope
This report quantifies the global Neuromodulation Devices and Implantable Infusion Pumps market in terms of revenue (US$ million) and, where applicable, sales volume (Unit), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Unit) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neuromodulation Devices and Implantable Infusion Pumps Market by Company
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
Parkinson's Disease
Epilepsy
Pain
Other
Neuromodulation Devices and Implantable Infusion Pumps Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuromodulation Devices and Implantable Infusion Pumps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neuromodulation Devices and Implantable Infusion Pumps and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuromodulation Devices and Implantable Infusion Pumps.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neuromodulation Devices and Implantable Infusion Pumps by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neuromodulation Devices and Implantable Infusion Pumps in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagal Nerve Stimulation
- Gastric Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Stimulation
- Other
Applications
- Parkinson's Disease
- Epilepsy
- Pain
- Other
Companies covered
- Medtronic
- Boston Scientific Corporation
- St. Jude Medical
- Synapse Biomedical
- Nevro Corporation
- Neuropace
- Cyberonics
- Autonomic Technologies
- Avery Biomedical
- Greatbatch Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (2021-2032)
- 2.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales (2021-2032)
- 2.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Average Price (2021-2032)
- 2.3 Neuromodulation Devices and Implantable Infusion Pumps by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Spinal Cord Stimulation
- 2.3.3 Deep Brain Stimulation
- 2.3.4 Sacral Nerve Stimulation
- 2.3.5 Vagal Nerve Stimulation
- 2.3.6 Gastric Stimulation
- 2.3.7 Transcranial Magnetic Stimulation
- 2.3.8 Transcutaneous Electrical Stimulation
- 2.3.9 Other
- 2.4 Neuromodulation Devices and Implantable Infusion Pumps by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Parkinson's Disease
- 2.4.3 Epilepsy
- 2.4.4 Pain
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) of Manufacturers (2021-2026)
- 3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue of Manufacturers (2021-2026)
- 3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2021-2026)
- 3.5 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Type & Application
- 3.8 Global Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Established Date
- 3.9 Global Neuromodulation Devices and Implantable Infusion Pumps Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Boston Scientific Corporation
- 4.2.1 Boston Scientific Corporation Company Information
- 4.2.2 Boston Scientific Corporation Business Overview
- 4.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.2.5 Boston Scientific Corporation Recent Developments
- 4.3 St. Jude Medical
- 4.3.1 St. Jude Medical Company Information
- 4.3.2 St. Jude Medical Business Overview
- 4.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.3.5 St. Jude Medical Recent Developments
- 4.4 Synapse Biomedical
- 4.4.1 Synapse Biomedical Company Information
- 4.4.2 Synapse Biomedical Business Overview
- 4.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.4.5 Synapse Biomedical Recent Developments
- 4.5 Nevro Corporation
- 4.5.1 Nevro Corporation Company Information
- 4.5.2 Nevro Corporation Business Overview
- 4.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.5.5 Nevro Corporation Recent Developments
- 4.6 Neuropace
- 4.6.1 Neuropace Company Information
- 4.6.2 Neuropace Business Overview
- 4.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.6.5 Neuropace Recent Developments
- 4.7 Cyberonics
- 4.7.1 Cyberonics Company Information
- 4.7.2 Cyberonics Business Overview
- 4.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.7.5 Cyberonics Recent Developments
- 4.8 Autonomic Technologies
- 4.8.1 Autonomic Technologies Company Information
- 4.8.2 Autonomic Technologies Business Overview
- 4.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.8.5 Autonomic Technologies Recent Developments
- 4.9 Avery Biomedical
- 4.9.1 Avery Biomedical Company Information
- 4.9.2 Avery Biomedical Business Overview
- 4.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.9.5 Avery Biomedical Recent Developments
- 4.10 Greatbatch Medical
- 4.10.1 Greatbatch Medical Company Information
- 4.10.2 Greatbatch Medical Business Overview
- 4.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 4.10.5 Greatbatch Medical Recent Developments
5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Scenario by Region
- 5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021-2032
- 5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021-2026
- 5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2027-2032
- 5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2021-2032
- 5.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2021-2026
- 5.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2027-2032
- 5.4 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
- 5.4.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
- 5.4.3 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
- 5.5.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
- 5.5.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
- 5.6.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
- 5.7.1 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
- 5.7.3 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032)
- 6.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032) & (Unit)
- 6.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2032)
- 6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032)
- 6.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2032)
- 6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032)
- 7.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032) & (Unit)
- 7.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2032)
- 7.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032)
- 7.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2032)
- 7.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
- 8.1.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
- 8.2 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
- 8.2.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
9 Global Neuromodulation Devices and Implantable Infusion Pumps Analyzing Market Dynamics
- 9.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
- 9.2 Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers
- 9.3 Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges
- 9.4 Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst